· Methods in molecular biology· Vol 3074, pp.
529-541
· 0 citations
Medicine
TL;DR
This chapter describes two in vitro assays designed to assess the hematopoietic stem/progenitor cell (HSPC)-supporting capacity of primed MSCs, and the other is specifically aimed at their ability to support the growth of primitive HSCs.
A protocol to isolate and expand MSCs from human umbilical cord tissue and characterize their cell surface protein expression by flow cytometry, self-renewal potential by colony-forming assay, and tri-lineage differentiation capacity is outlined.
Yi-Xuan Dai, Avital Mendelson· Methods in molecular biology· 0 citations
Background/Objectives: Mesenchymal stromal cells (MSCs) isolated from neonatal sources have been proposed in clinical cell therapy to enhance hematopoietic stem cell transplantation due to their hematopoietic support capacity. Here we evaluated this capacity, particularly the lymphopoietic potential that remains poorly...
Ixel Luna-Cañedo, G. Fajardo-Orduña, R. Pelayo et al.· Biomedicines· 0 citations
These cells can be isolated from a wide range of human tissues, including bone marrow (BM-MSCs), adipose tissue (AD-MSCs), dental tissues, such as dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs), as well as umbilical cord cells (UC-MSCs), including Wharton’s jelly–derived MSCs (UC-MSCs-WJ) a...
Letícia Odaguiri Watanabe, Luana Roleto Cardoso, Johnny Carvalho da Silva et al.· Biogerontology (Dordrecht)· 0 citations
Background: Mesenchymal stromal cells (MSCs) are among the most extensively studied candidates for cell-based therapy. The homing capacity of MSCs is a critical factor influencing the efficacy of MSC-based therapies. This study aimed to investigate the homing of placenta-derived mesenchymal stromal cells (PD-MSCs) in v...
Nasser Ahmadbeigi, S. Muhammadnejad, A. Muhammadnejad et al.· Advanced Biomedical Research· 0 citations
This integrated bone marrow organoid platform provides a physiologically relevant system for studying human hematopoietic development and immune cell differentiation and offers a scalable foundation for regenerative medicine and immunotherapy applications.
Jiyoung Lee, Tomoyuki Kawasaki, Lilika Tabata et al.· Stem cell research & therape...· 0 citations
BACKGROUND
Acute graft-versus-host disease (aGVHD) remains a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The development of methods that preserve graft-versus-leukemia (GVL) activity while preventing aGVHD remains a long-sought goal. Recent studies sugg...
Ya Zhou, Rui Wang, Zheng Wang et al.· Chinese Medical Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.